Intravesical gemcitabine and docetaxel in the treatment of BCG-naïve non–muscle invasive urothelial carcinoma of the bladder: Updates from a phase 2 trial.
PURPOSETo evaluate the efficacy and safety of first-line, single-agent trastuzumab in women with HER2-overexpressing metastatic breast cancer.PATIENTS AND METHODSOne hundred fourteen women with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results